ChromaCode Stock

ChromaCode is a biotechnology company that specializes in developing molecular diagnostics solutions. Founded in 2012 and headquartered in Carlsbad, California, the company's core technology is based on proprietary mathematical algorithms that enable the simultaneous detection of multiple DNA and RNA targets in a single reaction. ChromaCode harnesses the power of data science and advanced algorithms aiming to enhance the accuracy, efficiency, and affordability of diagnostic testing. Their solutions encompass infectious disease testing, genetic testing, oncology diagnostics, and more. The company works closely with clinical laboratories, healthcare providers, and regulatory agencies to ensure that their solutions meet rigorous quality standards and regulatory requirements.